Sen. Padilla Pushes, But DEA Nominee Terry Cole Won’t Commit to Cannabis Rescheduling

Cnannabis and CBD oil
Photo by Getty Images on Unsplash. Unsplash+ License obtained by editor.
Published: 30 Apr, 2025
Updated: 18 Jun, 2025
3 min read

WASHINGTON, D.C. - During his confirmation hearing before the Senate Judiciary Committee on April 30, DEA administrator nominee Terrance Cole declined to commit to the proposed federal rescheduling of cannabis, leaving a critical policy question unresolved as the process transitions to new leadership under the Trump administration.

The popular and game-changing rescheduling proposal backed by Donald J. Trump to reclassify cannabis from Schedule I to Schedule III under the federal Controlled Substances Act (CSA) remains formally active but administratively paused by a DEA judge.

If enacted, rescheduling cannabis to Schedule III would formally acknowledge the accepted medical use of cannabis under federal law. It would also allow for FDA-supervised research and development of cannabis-based drugs. 

Although cannabis would still be classified as a controlled substance and remain under the oversight of the DEA and FDA, reclassifying it to Schedule III would significantly benefit legal cannabis businesses by changing how they are treated under federal tax law.

Specifically, it would exempt them from the limitations of Section 280E of the Internal Revenue Code, which currently bars businesses trafficking in Schedule I or II substances from deducting ordinary business expenses. Due to this restriction, legitimate cannabis companies paid over $1.8 billion more in federal taxes in 2022 than comparable non-cannabis businesses, according to data from Whitney Economics.

Reclassification would not federally legalize recreational cannabis, authorize interstate commerce, or override any state-level prohibitions. 

Reclassification was initiated nearly three years ago during the Biden administration. Still, on January 13, 2025, one week before President Trump took office, the DEA’s Chief Administrative Law Judge cancelled a public hearing scheduled for January 21 and ordered parties to check back in with him in 90 days.

There is no statutory deadline for the DEA to complete the rescheduling process, so the current pause could extend indefinitely.  

Cole, a longtime DEA official nominated to be administrator in February, told lawmakers on April 30 that reviewing the agency’s stalled administrative process to move cannabis from Schedule I to Schedule III would be “one of [his] first priorities.” 

IVP Donate

Though cannabis was not mentioned in Cole’s opening remarks, he emphasized a focus on combating the fentanyl crisis and leveraging his 30 years in law enforcement to address cartel-related threats. “It’s time to move forward,” he said of the stalled rescheduling process.

But when pressed by US Senator Alex Padilla (D-CA) on whether he would ensure the proposed rescheduling is carried out, Cole would not commit. Here is a bit of back and forth between the two:

“I need to understand more where they are and look at the science behind it and listen to the experts and really understand where they are in the process,” Cole said.

Padilla, referencing the directive initiated in 2022, reiterated: “We know where we are. We know what the directive is: Get it to Schedule III. Are you committed to seeing it to fruition?”

Cole responded, “So, I don’t know. I haven’t seen that, sir.”

“So, you’re leaving the door open to changing course as to—?” Padilla asked.

“I’m leaving the door open to studying everything that’s been done so far, so I can make a determination, sir,” Cole said.

Padilla concluded the exchange by stating: “So, make myself a note here—no answer to that particular question.”

Let Us Vote : Sign Now!

Cole’s confirmation hearing made clear that even though the administrative reins are about to change hands at the DEA, the political and legal path for cannabis rescheduling at the federal level remains stuck.

Related articles

10 reasons nothing ever gets done on the border
10 Reasons Nothing Ever Gets Done on the Border Crisis
ICE raids, Los Angeles riots, “No King” protests. It’s all people can talk about these days as immigration is front and center in the American social and political zeitgeist. For many voters, this all may seem familiar....
13 Jun, 2025
-
11 min read
Medicine tablets next 50 dollar bills.
Everyone Agrees There’s Medicare Waste to Cut — Here’s Why It Hasn’t Happened
As the Senate takes up the House-passed One Big Beautiful Bill Act (OBBBA), some lawmakers are considering a slate of Medicare reforms aimed at reducing waste, fraud, and abuse within the program, which analysts say can be achieved through specific reforms that are not tied to partisan agendas....
10 Jun, 2025
-
5 min read
Elderly woman sitting in wheelchair staring out window.
Three Reps Put Party Labels Aside to Strengthen U.S. Role in Global Fight Against Alzheimer’s
Two California members of Congress, Ami Bera, M.D. (D-CA-06) and Young Kim (R-CA-40), introduced a bill Wednesday with Republican Pennsylvania Rep. Brian Fitzpatrick aimed at bolstering the US's global role in the battle against Alzheimer’s disease. ...
04 Jun, 2025
-
3 min read

Latest articles

A man filling out his election ballot.
Oregon Activist Sues over Closed Primaries: 'I Shouldn't Have to Join a Party to Have a Voice'
A new lawsuit filed in Oregon challenges the constitutionality of the state’s closed primary system, which denies the state’s largest registered voting bloc – independent voters – access to taxpayer-funded primary elections. The suit alleges Oregon is denying the voters equal voting rights...
01 Jul, 2025
-
3 min read
Supreme Court building.
Supreme Court Sides with Federal Corrections Officers in Lawsuit Over Prison Incident
The U.S. Supreme Court ruled June 30 that federal prison officers and officials cannot be sued by an inmate who accused them of excessive force during a 2021 incident, delivering a victory for federal corrections personnel concerned about rising legal exposure for doing their jobs....
01 Jul, 2025
-
3 min read
Marijuana plant.
Why the War on Cannabis Refuses to Die: How Boomers and the Yippies Made Weed Political
For much of the eighteenth and nineteenth centuries, American physicians freely prescribed cannabis to treat a wide range of ailments. But by the mid-twentieth century, federal officials were laying the groundwork for a sweeping criminal crackdown. Cannabis would ultimately be classified as a Schedule I substance, placed alongside heroin and LSD, and transformed into a political weapon that shaped American policy for the next six decades....
30 Jun, 2025
-
2 min read